Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice
Leilani L. Santos(Royal Women's Hospital), Eric F. Morand(Novartis (Switzerland)), Günter Fingerle-Rowson(University Hospital Cologne), Michael J. Hickey(Australian Regenerative Medicine Institute), Charles R. Mackay(Discovery Institute), Pam Hall(Monash Medical Centre), Huapeng Fan(Monash Medical Centre), Devi Ngo(Monash Medical Centre), Richard Bucala(Yale University)
Cited by 86
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
|The Journal of Immunology|2001|957
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
|Annals of the Rheumatic Diseases|2015|728
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726